Critical Survey: Curaleaf (OTCMKTS:CURLF) versus LogicMark (OTCMKTS:LGMKD)

LogicMark (OTCMKTS:LGMKD) and Curaleaf (OTCMKTS:CURLF) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for LogicMark and Curaleaf, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LogicMark	0	1	0	0	2.00
Curaleaf	0	1	2	1	3.00

Curaleaf has a consensus price target of $6.00, suggesting a potential downside of 23.47%. Given Curaleaf’s stronger consensus rating and higher probable upside, analysts clearly believe Curaleaf is more favorable than LogicMark.

Insider & Institutional Ownership

7.9% of LogicMark shares are owned by institutional investors. Comparatively, 0.0% of Curaleaf shares are owned by institutional investors. 2.2% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares LogicMark and Curaleaf”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LogicMark	$9.90 million	0.12	-$9.00 million	($94.52)	-0.01
Curaleaf	$1.27 billion	1.44	-$231.07 million	($0.13)	-60.31

LogicMark has higher earnings, but lower revenue than Curaleaf. Curaleaf is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

LogicMark has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, Curaleaf has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.

Profitability

This table compares LogicMark and Curaleaf’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LogicMark	-90.21%	-57.08%	-44.90%
Curaleaf	-2.62%	-0.88%	-0.26%

Summary

Curaleaf beats LogicMark on 10 of the 15 factors compared between the two stocks.

About LogicMark

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.